{"id":"https://openalex.org/W1995142365","doi":"https://doi.org/10.1097/01.yic.0000068045.82050.00","title":"A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care","display_name":"A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care","alternate_titles":[],"publication_year":2003,"publication_date":"2003-05-01","ids":{"openalex":"https://openalex.org/W1995142365","doi":"https://doi.org/10.1097/01.yic.0000068045.82050.00","mag":"1995142365","pmid":"https://pubmed.ncbi.nlm.nih.gov/12702891"},"language":"en","primary_location":{"id":"doi:10.1097/01.yic.0000068045.82050.00","doi":"https://doi.org/10.1097/01.yic.0000068045.82050.00","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.yic.0000068045.82050.00","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1995142365"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111522890","display_name":"Alan G. Wade","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Alan Wade","raw_affiliation_strings":["Community Pharmacology Services Ltd (CPS), Clydebank, Glasgow, UK","and requests for reprints to Dr Alan Wade, Community Pharmacology Services Ltd (CPS), Riverside Medipark, Clydebank, Glasgow G81 4SA, UK","Received 29 October 2002 Accepted 27 February 2003","Tel: +44 (0) 141 9515444","e-mail: [email\u00a0protected]","fax: +44 (0) 141 9515432"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Community Pharmacology Services Ltd (CPS), Clydebank, Glasgow, UK","institution_ids":[]},{"raw_affiliation_string":"and requests for reprints to Dr Alan Wade, Community Pharmacology Services Ltd (CPS), Riverside Medipark, Clydebank, Glasgow G81 4SA, UK","institution_ids":[]},{"raw_affiliation_string":"Received 29 October 2002 Accepted 27 February 2003","institution_ids":[]},{"raw_affiliation_string":"Tel: +44 (0) 141 9515444","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +44 (0) 141 9515432","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109990885","display_name":"Gordon M. Crawford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gordon M Crawford","raw_affiliation_strings":["Community Pharmacology Services Ltd (CPS), Clydebank, Glasgow, UK","Received 29 October 2002 Accepted 27 February 2003","Tel: +44 (0) 141 9515444","e-mail: [email\u00a0protected]","fax: +44 (0) 141 9515432"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Community Pharmacology Services Ltd (CPS), Clydebank, Glasgow, UK","institution_ids":[]},{"raw_affiliation_string":"Received 29 October 2002 Accepted 27 February 2003","institution_ids":[]},{"raw_affiliation_string":"Tel: +44 (0) 141 9515444","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +44 (0) 141 9515432","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050102329","display_name":"Margaret Angus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Margaret Angus","raw_affiliation_strings":["Community Pharmacology Services Ltd (CPS), Clydebank, Glasgow, UK","Received 29 October 2002 Accepted 27 February 2003","Tel: +44 (0) 141 9515444","e-mail: [email\u00a0protected]","fax: +44 (0) 141 9515432"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Community Pharmacology Services Ltd (CPS), Clydebank, Glasgow, UK","institution_ids":[]},{"raw_affiliation_string":"Received 29 October 2002 Accepted 27 February 2003","institution_ids":[]},{"raw_affiliation_string":"Tel: +44 (0) 141 9515444","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +44 (0) 141 9515432","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard Wilson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Wilson","raw_affiliation_strings":["Community Pharmacology Services Ltd (CPS), Clydebank, Glasgow, UK","Received 29 October 2002 Accepted 27 February 2003","Tel: +44 (0) 141 9515444","e-mail: [email\u00a0protected]","fax: +44 (0) 141 9515432"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Community Pharmacology Services Ltd (CPS), Clydebank, Glasgow, UK","institution_ids":[]},{"raw_affiliation_string":"Received 29 October 2002 Accepted 27 February 2003","institution_ids":[]},{"raw_affiliation_string":"Tel: +44 (0) 141 9515444","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +44 (0) 141 9515432","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Lorna Hamilton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lorna Hamilton","raw_affiliation_strings":["Community Pharmacology Services Ltd (CPS), Clydebank, Glasgow, UK","Received 29 October 2002 Accepted 27 February 2003","Tel: +44 (0) 141 9515444","e-mail: [email\u00a0protected]","fax: +44 (0) 141 9515432"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Community Pharmacology Services Ltd (CPS), Clydebank, Glasgow, UK","institution_ids":[]},{"raw_affiliation_string":"Received 29 October 2002 Accepted 27 February 2003","institution_ids":[]},{"raw_affiliation_string":"Tel: +44 (0) 141 9515444","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +44 (0) 141 9515432","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5111522890"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.7398,"has_fulltext":false,"cited_by_count":66,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.88414999,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"18","issue":"3","first_page":"133","last_page":"141"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mirtazapine","display_name":"mirtazapine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":1.0},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9929999709129333},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.8349999785423279},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.8029999732971191},{"id":"https://openalex.org/keywords/primary-care-depression","display_name":"primary care depression","score":0.7580000162124634},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.906000018119812},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.531000018119812},{"id":"https://openalex.org/keywords/sweating","display_name":"sweating","score":0.8930000066757202},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5019999742507935},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.4790000021457672},{"id":"https://openalex.org/keywords/clinical-global-improvement","display_name":"Clinical Global Improvement","score":0.7260000109672546}],"concepts":[{"id":"https://openalex.org/C2781068410","wikidata":"https://www.wikidata.org/wiki/Q421930","display_name":"Mirtazapine","level":4,"score":0.9480780363082886},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.8854182362556458},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8135801553726196},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5579081177711487},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5255866646766663},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5057117938995361},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4851604104042053},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47055649757385254},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.46981456875801086},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46897467970848083},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4112032353878021},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3993627429008484},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000078785","descriptor_name":"Mirtazapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006261","descriptor_name":"Headache","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011320","descriptor_name":"Primary Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013546","descriptor_name":"Sweating","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/01.yic.0000068045.82050.00","doi":"https://doi.org/10.1097/01.yic.0000068045.82050.00","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.yic.0000068045.82050.00","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"doi:10.1097/00004850-200305000-00002","doi":"https://doi.org/10.1097/00004850-200305000-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-200305000-00002","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:12702891","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12702891","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1567227424","https://openalex.org/W1855938261","https://openalex.org/W1999522182","https://openalex.org/W2005152385","https://openalex.org/W2005597128","https://openalex.org/W2018830357","https://openalex.org/W2025534441","https://openalex.org/W2043046773","https://openalex.org/W2056462900","https://openalex.org/W2058750823","https://openalex.org/W2070395519","https://openalex.org/W2071214152","https://openalex.org/W2113769474","https://openalex.org/W2114613490","https://openalex.org/W2141936870","https://openalex.org/W2164182651","https://openalex.org/W2168271065","https://openalex.org/W2169496899","https://openalex.org/W2262396283"],"related_works":["https://openalex.org/W2168271065","https://openalex.org/W1538582844","https://openalex.org/W2375707730","https://openalex.org/W2025424385","https://openalex.org/W2005597128","https://openalex.org/W2382439702","https://openalex.org/W2365938158","https://openalex.org/W2028123499","https://openalex.org/W2382441993","https://openalex.org/W2077023044"],"abstract_inverted_index":{"Primary":[0],"care":[1],"patients":[2,138,166,186],"with":[3,25,85,122],"a":[4,123],"major":[5],"depressive":[6,41],"disorder":[7],"and":[8,54,56,80,82,98,108,144,152,156,181,195],"17-item":[9],"Hamilton":[10],"Rating":[11],"Scale":[12],"for":[13,161],"Depression":[14],"(17-HAM-D)":[15],"score":[16],">18":[17],"were":[18,37,115,154],"randomized":[19],"to":[20,191],"24":[21,162],"weeks":[22,77,96,163,179],"of":[23,51,92,111,140,202],"treatment":[24],"mirtazapine":[26,62,130,151,177,185,203],"30-45":[27],"mg/day":[28,33],"(n=99)":[29],"or":[30],"paroxetine":[31,87,153],"20-30":[32],"(n=98).":[34],"Both":[35,113],"treatments":[36,114],"efficacious":[38,155],"in":[39,71,128,164,168,174,199],"improving":[40],"symptomatology,":[42],"as":[43],"assessed":[44],"by":[45],"group":[46,63,72,88,131],"mean":[47,73],"17-HAM-D":[48,74],"scores,":[49],"percentages":[50],"HAM-D":[52],"responders":[53],"remitters":[55],"Clinical":[57],"Global":[58],"Improvement":[59],"responders.":[60],"The":[61,118,146],"showed":[64],"statistically":[65,124],"significantly":[66,125,135],"larger":[67],"decreases":[68],"from":[69],"baseline":[70],"scores":[75],"at":[76,95],"1,":[78],"2":[79,97],"4,":[81],"the":[83,86,90,106,129],"difference":[84,173],"reached":[89],"level":[91],"clinical":[93],"relevance":[94],"4.":[99],"Antidepressant":[100],"efficacy":[101,175],"was":[102,132],"maintained":[103],"throughout":[104],"both":[105,150],"acute":[107],"continuation":[109],"phase":[110],"treatment.":[112],"well":[116,157],"tolerated.":[117],"only":[119],"adverse":[120],"event":[121],"higher":[126],"incidence":[127],"fatigue.":[133],"Statistically":[134],"more":[136],"paroxetine-treated":[137],"complained":[139],"increased":[141],"sweating,":[142],"headache":[143],"nausea.":[145],"results":[147],"demonstrate":[148],"that":[149,184],"tolerated":[158],"when":[159],"used":[160],"depressed":[165],"treated":[167],"primary":[169],"care.":[170],"An":[171],"observed":[172],"favouring":[176],"between":[178],"1":[180],"4":[182],"indicates":[183],"had":[187],"improved":[188],"earlier":[189],"compared":[190],"those":[192],"on":[193],"paroxetine,":[194],"corroborates":[196],"similar":[197],"findings":[198],"other":[200],"comparisons":[201],"versus":[204],"selective":[205],"serotonin":[206],"reuptake":[207],"inhibitors.":[208]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1995142365","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
